access your medical records
Home > Research at Avera > Clinical Trials at Avera > Clinical Trials Search Results
The purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis.
This study is designed to evaluate the safety and efficacy of nonconforming idecabtagene vicleucel (ide-cel) in subjects with multiple myeloma per the approved prescribing information.
Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2.
© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.